Post on 23-Feb-2016
description
MALARIA AND NEGLECTED TROPICAL DISEASES (NTDs):
FINDINGS FROM THE 2012 G-FINDER REPORT
Policy Cures
Innovative ideas and accurate analysis to accelerate development and uptake of new drugs, vaccines, diagnostics and other products for neglected diseases of the developing world
• Annual survey of global investment into R&D of new neglected disease products
• Neutral, comparable, comprehensive analysis
• Commissioned by the Bill & Melinda Gates Foundation
• 31 neglected diseases• 134 product areas• All R&D stages
G-FINDER
$84.9m higher in 2011 than in 2007
Malaria – overall funding
Malaria – by product area
• Vaccines, diagnostics and vector control R&D ↑
• Drug R&D →
• Basic research ↑
Who funds malaria R&D?
Gates Foundation 26.3%
US NIH 20.7%
Industry (aggregate) 18.7%
66%
NTDs
50% 65%
Buruli ulcerDengueKinetoplastids (Chagas, HAT, leishmaniasis)
Helminths (lymphatic filariasis, STHs, cysticercosis, onchocerciasis, schistosomiasis)
LeprosyTrachoma
HIV/AIDS
Malaria
TB
Diarrhoeal diseases
Bacterial pneumonia & meningitis
Salmonella infections
Rheumatic fever
Guinea worm disease
Echinococcosis
Foodborne trematode infections
Rabies
Yaws
WHO classification G-FINDER
NTDs – dengue, kinetoplastids and helminths
NTDs – leprosy, Buruli ulcer and trachoma
$7.4m$5.8m $9.6m
Download the full report atwww.policycures.org/g-finder2012.html